Piper Sandler on DexCom (DXCM): 'Well Done Investor Meeting Provides Excellent Stock Setup'

May 15, 2026 8:55 AM

Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $75.00 price target on DexCom (NASDAQ: DXCM).The analyst commented: "Well ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found